2-(4-Chloro-2-fluoro-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 5g

(S)-3-Ethylmorpholine hydrochloride, 95.0%, 25g

2-(3-(3-Methoxyphenyl)allylidene)malonic acid, 95.0%, 5g

bScope BS.1152-EPLPH for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x

2,6-Dichloro-pyridine-3-sulfonyl chloride, 95.0%, 10g

4-(1h-Pyrrol-1-yl)benzene-1-sulfonamide, 97%, 250mg

1-Iodo-3,4-methylenedioxybenzene, 99.0%, 5g

Pentamethyldisiloxane, 95%, 5g

6,8-dichloro-2-(trifluoromethyl)-1,4-dihydroquinolin-4-one, 98%, 5g

3-Aminopentane>98.0%(GC)(T)100mL

4-HYDRAZINYLBUTAN-1-OL, 95.0%, 250mg

Oxion Inverso OX.2053-PL with LWD Plan 10x/20x/40x objectives and XY cross table

Ethyl (S)-2-aminopent-4-enoate hydrochloride, 98%, 100mg